Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
413
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

454
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
454
  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Ophthalmology And Optometry
  5. Optical Technology
  6. Predictive Value Of Short-term Steroid Intraocular Pressure Elevation Testing For Long-term Steroid Intraocular Pressure Elevation In Diabetic Macular Edema Treatment

Predictive value of short-term steroid intraocular pressure elevation testing for long-term steroid intraocular pressure elevation in diabetic macular edema treatment

Catarina Pestana Aguiar1, João Alves Ambrósio2, Vítor Miranda2

  • 1Unidade Local de Saúde Entre Douro e Vouga, Santa Maria da Feira, Portugal. catarina.pestana.aguiar@gmail.com.

International Ophthalmology
|June 12, 2025

Related Experiment Videos

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.3K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

32.1K

View abstract on PubMed

Summary
This summary is machine-generated.

Intraocular pressure (IOP) elevation after intravitreal triamcinolone acetonide (TA) testing does not predict IOP response to fluocinolone acetonide (FAc) implants for diabetic macular edema. A prior TA challenge may not reliably indicate FAc implant outcomes.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetic macular edema (DME) management often involves corticosteroids.
  • Intraocular pressure (IOP) elevation is a known side effect of intravitreal steroids.
  • Predicting individual steroid response is crucial for treatment selection.

Purpose of the Study:

  • To determine if IOP elevation after intravitreal triamcinolone acetonide (TA) predicts IOP response to fluocinolone acetonide (FAc) implants in DME patients.
  • To analyze the correlation between IOP changes following two different intravitreal steroid treatments.

Main Methods:

  • Retrospective observational cohort study of 28 eyes.
  • Patients received intravitreal TA followed by a FAc implant.
  • IOP measured before and after both treatments; steroid response defined as IOP > 21 mmHg.
Keywords:
Fluocinolone acetonide implantIntraocular pressureIntravitreal injectionsMacular diabetic edema

Related Experiment Videos

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.3K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

32.1K

Main Results:

  • No statistically significant correlation found between TA-induced IOP elevation and subsequent FAc-induced IOP changes.
  • Six eyes showed a steroid response to TA; none of these responded to FAc.
  • Six additional eyes developed a steroid response to the FAc implant.

Conclusions:

  • The predictive value of a short-acting steroid (TA) challenge for long-acting steroid (FAc) implant response was not evident.
  • Relying on TA testing to predict FAc implant outcomes may not be useful.
  • Consideration of prolonged steroid implants may be beneficial despite risks of relapse.
Triamcinolone acetonide